0001104659-21-028471.txt : 20210225 0001104659-21-028471.hdr.sgml : 20210225 20210225212504 ACCESSION NUMBER: 0001104659-21-028471 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210225 FILED AS OF DATE: 20210225 DATE AS OF CHANGE: 20210225 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: UKWU HENRIETTA CENTRAL INDEX KEY: 0001840591 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40119 FILM NUMBER: 21683343 MAIL ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IBERE PHARMACEUTICALS CENTRAL INDEX KEY: 0001835205 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 981564986 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: 267-765-3222 MAIL ADDRESS: STREET 1: 2005 MARKET STREET, SUITE 2030 CITY: PHILADELPHIA STATE: PA ZIP: 19103 3 1 tm217951d4_3.xml OWNERSHIP DOCUMENT X0206 3 2021-02-25 0 0001835205 IBERE PHARMACEUTICALS IBER 0001840591 UKWU HENRIETTA C/O IBERE PHARMACEUTICALS 2005 MARKET STREET, SUITE 2030 PHILADELPHIA PA 19103 1 0 0 0 Class B Ordinary Shares Class A Ordinary Shares 25000 D As described in the issuer's registration statement on Form S-1 (File No. 333-252863) (the "Registration Statement") under the heading "Description of Securities--Founder Shares," the shares of Class B ordinary shares, par value $0.0001 per share, will automatically be converted into shares of Class A ordinary shares, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis subject to adjustment pursuant to certain anti-dilution rights described therein. /s/ Henrietta Ukwu 2021-02-25